other material
confidence high
sentiment neutral
materiality 0.70
Tempest raises $4.25M upfront in registered direct offering; warrants add up to $4.1M
Tempest Therapeutics, Inc.
- 1,172,414 shares (or equivalents) sold at $3.625/share in registered direct offering for ~$4.25M gross.
- Concurrent private placement of short-term warrants to buy 1,172,414 shares at $3.50, exercisable for 18 months.
- Warrants could yield additional ~$4.1M proceeds if fully exercised on a cash basis, but no guarantee.
- Net proceeds used for working capital and general corporate purposes; H.C. Wainwright placement agent with 6% fee.